Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in newborns with retinopathy of prematurity
NCT03038295Phase 2Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of propranolol in retinopathy of prematurity (ROP), sponsored by Guangdong Women and Children Hospital. Status: unknown.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT03038295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038295.